Search
for
Sort by
Research 30 of 1000+
- In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
- A practical guide for the study of human and murine sebaceous glands <i>in situ</i>
- LB1773 Dutasteride in the treatment of frontal fibrosing alopecia: Systematic review and meta-analysis
- Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System
- Clinical, trichoscopic, and folliscopic identification of the impact of metabolic syndrome on the response to intradermal dutasteride 0.02% injection in patients with female pattern hair loss: a prospective cohort study
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation
- The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia
- A0366 Comparative effects of finasteride and dutasteride on semen parameters in young men with androgenic alopecia: A randomized controlled study
- 3D analysis of facial morphology in Dutch children with cancer
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
- An update on hair restoration therapy
- Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA
- Inhibition of 5α-reductase alters pregnane metabolism in the late pregnant mare
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Contraindicated use of 5-alpha-reductase inhibitors in women
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study
- “Effectiveness of minimally invasive injectable modalities in the management of androgenetic alopecia among adults—A systematic review”
- 5 Alpha Reductase Inhibitors
- Blood donors on teratogenic drugs and donor deferral periods in a clinical situation
- New Drugs: Dutasteride
- Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo‐controlled study
- The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
- Nanomilled Oral Testosterone Plus Dutasteride Effectively Normalizes Serum Testosterone in Normal Men With Induced Hypogonadism
- Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review